Last month, the Iranian government announced that due to increasing levels of infertility, it will now help fund up to 85% of infertility treatments at state hospitals for families wishing to conceive. Studies by medical researchers show that more than 20% of Iranian couples cannot conceive, compared with the global rate of between 8% and 12%. The Iranian government’s latest move is yet another step by the Islamic Republic to encourage childbearing, which Supreme Leader Ayatollah Ali Khamenei has been campaigning for in recent years. In this vein, family planning budgets have been cut and prevention methods such as vasectomies have been banned.
Iran has long been a leader in the Middle East on treating infertility, with nearly 100 clinics nationwide that serve not only Iranian couples, but also couples from neighboring states who come to take advantage of the country’s open stance toward such treatments. Yet what remains an overarching question is why infertility rates in Iran have jumped above the global average.
Measuring the causes of infertility remains difficult for the scientific community. In the case of Iran, some medical researchers in the country point to the possibility of high levels of air pollution in recent years having an adverse effect on reproduction. But countries such as China and Mexico have had much higher levels of pollution for longer periods of time, and we do not see spikes in levels of infertility. As such, while pollution can be a contributing factor, it is not the only factor.
More broadly, infertility rates in the Middle East are high compared with global averages. Marcia Inhorn, a medical anthropologist at Yale University who specializes in assisted reproduction in the region, points to the high rate of marriages between cousins in the Middle East, especially first cousins, as a leading cause. Male infertility is “the hidden story of the Middle East,” she argues in her findings, which are the results of decades of research on the ground in the region.
AL-MONITOR All-Access gives you unlimited access to all our journalism, the full Daily Briefing, exclusive interviews, premium newsletters, and live events — for less than $2/week.